Analyst firms · H.C. Wainwright · COLL
H.C. Wainwright COLL price target and rating history
Collegium Pharmaceutical Inc. (COLL) · Health Care
H.C. Wainwright rates Collegium Pharmaceutical Inc. (COLL) Buy with a $47 price target, as of its latest action on Jul 30, 2024. It has published 4 rating actions on COLL since August 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.
- Current rating
- Buy
- Price target
- $47
- Median target, all firms
- $49.50
- Actions on COLL
- 4
H.C. Wainwright price target on COLL
Every H.C. Wainwright rating on COLL
- Jul 30, 2024
- Aug 8, 2022
- Feb 15, 2022
- Aug 6, 2021
How other firms rate COLL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Oppenheimer | Outperform | $50 | Sep 23, 2026 |
| Truist Securities | Buy | $49 | Sep 9, 2026 |
| Leerink Partners | Outperform | $45 | Sep 9, 2026 |
| Barclays | Overweight | $58 | Dec 9, 2025 |
Questions about H.C. Wainwright and COLL
- What is H.C. Wainwright's price target for COLL?
- H.C. Wainwright's latest stated price target for Collegium Pharmaceutical Inc. (COLL) is $47, from its action on Jul 30, 2024.
- What is H.C. Wainwright's rating on COLL?
- H.C. Wainwright rates COLL Buy, a bullish rating, as of Jul 30, 2024.
- When did H.C. Wainwright last change its view on COLL?
- On Jul 30, 2024, H.C. Wainwright upgrades to Buy from Neutral, price target $47.
- How does H.C. Wainwright's COLL target compare with other analysts?
- Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.
More COLL rating histories
All H.C. Wainwright ratingsCOLL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.